Intrabursal injection of vascular endothelial growth factor trap in eCG-treated prepubertal rats inhibits proliferation and increases apoptosis of follicular cells involving the PI3K/AKT signaling pathway

Fertility and Sterility

Volumn 93, Issue 5, 2010, Pages 1369-1377

  Abramovich, Dalhia ^a   Irusta, Griselda ^a   Parborell, Fernanda ^a   Tesone, Marta ^a,b  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

angiogenesis; apoptosis; Ovary; PI3K AKT; proliferation; VEGFA

Indexed keywords

CASPASE 3; CHORIONIC GONADOTROPIN; CYCLINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; RAC PROTEIN; SERINE; THREONINE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL DENSITY; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GRANULOSA CELL; INHIBITION KINETICS; NONHUMAN; OVARY FOLLICLE CELL; PREPUBERTY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; THECA CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CASPASE 3; CELL PROLIFERATION; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FEMALE; GONADOTROPINS, EQUINE; INJECTIONS; OVARIAN FOLLICLE; OVARY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; SEXUAL MATURATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77949264340     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.01.127     Document Type: Article

References (36)

1. Stouffer R.L., Martinez-Chequer J.C., Molskness T.A., Xu F., and Hazzard T.M. Regulation and action of angiogenic factors in the primate ovary. Arch Med Res 32 (2001) 567-575
2. Tamanini C., and De Ambrogi M. Angiogenesis in developing follicle and corpus luteum. Reprod Domest Anim 39 (2004) 206-216
3. Zeleznik A.J., Schuler H.M., and Reichert Jr. L.E. Gonadotropin-binding sites in the rhesus monkey ovary: role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle. Endocrinology 109 (1981) 356-362
4. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77 (1999) 527-543
5. Zimmermann R.C., Hartman T., Kavic S., Pauli S.A., Bohlen P., Sauer M.V., et al. Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development. J Clin Invest 112 (2003) 659-669
6. Wulff C., Wilson H., Wiegand S.J., Rudge J.S., and Fraser H.M. Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2. Endocrinology 143 (2002) 2797-2807
7. Hazzard T.M., Xu F., and Stouffer R.L. Injection of soluble vascular endothelial growth factor receptor 1 into the preovulatory follicle disrupts ovulation and subsequent luteal function in rhesus monkeys. Biol Reprod 67 (2002) 1305-1312
8. Abramovich D., Parborell F., and Tesone M. Effect of a vascular endothelial growth factor (VEGF) inhibitory treatment on the folliculogenesis and ovarian apoptosis in gonadotropin-treated prepubertal rats. Biol Reprod 75 (2006) 434-441
9. Parborell F., Abramovich D., and Tesone M. Intrabursal administration of the antiangiopoietin 1 antibody produces a delay in rat follicular development associated with an increase in ovarian apoptosis mediated by changes in the expression of BCL2 related genes. Biol Reprod 78 (2008) 506-513
10. Gerber H.P., Dixit V., and Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273 (1998) 13313-13316
11. Gerber H.P., McMurtrey A., Kowalski J., Yan M., Keyt B.A., Dixit V., et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273 (1998) 30336-30343
12. Gora-Kupilas K., and Josko J. The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol 43 (2005) 31-39
13. Rosenstein J.M., and Krum J.M. New roles for VEGF in nervous tissue-beyond blood vessels. Exp Neurol 187 (2004) 246-253
14. Rissanen T.T., Vajanto I., Hiltunen M.O., Rutanen J., Kettunen M.I., Niemi M., et al. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am J Pathol 160 (2002) 1393-1403
15. Greenaway J., Connor K., Pedersen H.G., Coomber B.L., LaMarre J., and Petrik J. Vascular endothelial growth factor and its receptor, Flk-1/KDR, are cytoprotective in the extravascular compartment of the ovarian follicle. Endocrinology 145 (2004) 2896-2905
16. Andjelkovic M., Alessi D.R., Meier R., Fernandez A., Lamb N.J., Frech M., et al. Role of translocation in the activation and function of protein kinase B. J Biol Chem 272 (1997) 31515-31524
17. Datta S.R., Brunet A., and Greenberg M.E. Cellular survival: a play in three Akts. Genes & Dev 13 (1999) 2905-2927
18. Fujio Y., and Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem 274 (1999) 16349-16354
19. Jin K.L., Mao X.O., and Greenberg D.A. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci U S A 97 (2000) 10242-10247
20. Banerjee S., Mehta S., Haque I., Sengupta K., Dhar K., Kambhampati S., et al. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis. Biochemistry 47 (2008) 3345-3351
21. Woodruff T.K., Lyon R.J., Hansen S.E., Rice G.C., and Mather J.P. Inhibin and activin locally regulate rat ovarian folliculogenesis. Endocrinology 127 (1990) 3196-3205
22. Rasband WS. Image J.U.S. National Institutes of Health, Bethesda, Maryland, USA. Available at: http://rsb.info.nih.gov/ij/. Accessed: 2009.
23. Tilly J.L., Billig H., Kowalski K.I., and Hsueh A.J. Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism. Mol Endocrinol 6 (1992) 1942-1950
24. Parborell F., Irusta G., Vitale A.M., Gonzalez O., Pecci A., and Tesone M. GnRH antagonist Antide inhibits apoptosis of preovulatory follicle cells in rat ovary. Biol Reprod 72 (2005) 659-666
25. Grasselli F., Basini G., Bussolati S., and Tamanini C. Effects of VEGF and bFGF on proliferation and production of steroids and nitric oxide in porcine granulosa cells. Reprod Domest Anim 37 (2002) 362-368
26. Boone D.L., and Tsang B.K. Caspase-3 in the rat ovary: localization and possible role in follicular atresia and luteal regression. Biol Reprod 58 (1998) 1533-1539
27. Xu F., Hazzard T.M., Evans A., Charnock-Jones S., Smith S., and Stouffer R.L. Intraovarian actions of anti-angiogenic agents disrupt periovulatory events during the menstrual cycle in monkeys. Contraception 71 (2005) 239-248
28. Jiang B.H., and Liu L.Z. PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta 1784 (2008) 150-158
29. Wulff C., Wiegand S.J., Saunders P.T., Scobie G.A., and Fraser H.M. Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap(A40)). Endocrinology 142 (2001) 3244-3254
30. Taylor P.D., Hillier S.G., and Fraser H.M. Effects of GnRH antagonist treatment on follicular development and angiogenesis in the primate ovary. J Endocrinol 183 (2004) 1-17
31. Hu L., Hofmann J., Holash J., Yancopoulos G.D., Sood A.K., and Jaffe R.B. Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model. Clin Cancer Res 11 (2005) 6966-6971
32. Le X.F., Mao W., Lu C., Thornton A., Heymach J.V., Sood A.K., et al. Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2. Cell Cycle 7 (2008) 3747-3758
33. Fraser H.M., Wilson H., Silvestri A., Morris K.D., and Wiegand S.J. The role of vascular endothelial growth factor and estradiol in the regulation of endometrial angiogenesis and cell proliferation in the marmoset. Endocrinology 149 (2008) 4413-4420
34. Rini B.I., and Rathmell W.K. Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinoma. Clin Cancer Res 13 (2007) 741s-746s
35. Riely G.J., and Miller V.A. Vascular endothelial growth factor trap in non small cell lung cancer. Clin Cancer Res 13 (2007) s4623-s4627
36. Nguyen Q.D., Shah S.M., Hafiz G., Quinlan E., Sung J., Chu K., et al. A phase I trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related macular degeneration. Ophthalmology 113 (2006) 1522e1-e14